LeadIQ logo
Learn more at LeadIQ.com
✕

Access Insights for Talaris Therapeutics and Millions of Other Companies

Sign up for full access to Talaris Therapeutics information.
No credit card needed
OR
By creating an account, you agree to LeadIQ's Terms of Use and Privacy Policy.

Insights

Acquisition Trends Talaris Therapeutics has recently been involved in multiple acquisitions and partnerships with other biotech companies, indicating potential collaborations or sales opportunities within the industry.

New Leadership With the appointment of Mary Kay Fenton as interim CEO and President, there may be opportunities for sales discussions as the company navigates leadership transitions and strategic direction changes.

Expansion of Services The acquisition of tolerance and genetic manufacturing facilities by various companies suggests potential demand for biotech services, presenting opportunities for Talaris Therapeutics to offer its expertise in the market.

Financial Resilience Despite recent ownership changes, Talaris Therapeutics shows financial strength with revenues between $10M to $50M and funding of $115M, signaling stability and potential for investment or collaboration.

Competitive Landscape By examining similar companies like Cabaletta Bio, NantKwest, and Kiadis Pharma, sales teams can identify potential clients or partners within the biotechnology sector based on employee size and revenue similarities.

Similar companies to Talaris Therapeutics

✕

Access Insights for Talaris Therapeutics and Millions of Other Companies

Sign up for full access to Talaris Therapeutics information.
No credit card needed
OR
By creating an account, you agree to LeadIQ's Terms of Use and Privacy Policy.

Talaris Therapeutics Tech Stack

Talaris Therapeutics uses 8 technology products and services including Google Analytics, Drupal, Modernizr, and more. Explore Talaris Therapeutics's tech stack below.

  • Google Analytics
    Analytics
  • Drupal
    Content Management System
  • Modernizr
    Javascript Libraries
  • reCAPTCHA
    Security
  • X-XSS-Protection
    Security
  • Vimeo
    Video Players
  • OpenResty
    Web Servers
  • Nginx
    Web Servers

Media & News

Talaris Therapeutics's Email Address Formats

Talaris Therapeutics uses at least 1 format(s):
Talaris Therapeutics Email FormatsExamplePercentage
First.Last@talaristx.comJohn.Doe@talaristx.com
87%
Last@talaristx.comDoe@talaristx.com
6%
First@talaristx.comJohn@talaristx.com
6%
Fir.Last@talaristx.comJoh.Doe@talaristx.com
1%

Frequently Asked Questions

Where is Talaris Therapeutics's headquarters located?

Minus sign iconPlus sign iconTalaris Therapeutics's main headquarters is located at Louisville, Kentucky 40202 US. The company has employees across 4 continents, including North AmericaEuropeAsia.

What is Talaris Therapeutics's stock symbol?

Minus sign iconPlus sign iconTalaris Therapeutics is a publicly traded company; the company's stock symbol is TRML.

What is Talaris Therapeutics's official website and social media links?

Minus sign iconPlus sign iconTalaris Therapeutics's official website is talaristx.com and has social profiles on LinkedIn.

How much revenue does Talaris Therapeutics generate?

Minus sign iconPlus sign icon As of November 2023, Talaris Therapeutics's annual revenue reached $15M.

What is Talaris Therapeutics's SIC code NAICS code?

Minus sign iconPlus sign iconTalaris Therapeutics's SIC code is 8733 - Noncommercial Research Organizations NAICS code is 541714 - Research and Development in Biotechnology (except Nanobiotechnology).

How many employees does Talaris Therapeutics have currently?

Minus sign iconPlus sign iconAs of November 2023, Talaris Therapeutics has approximately 51 employees across 4 continents, including North AmericaEuropeAsia. Key team members include Executive Assistant To The Chief Medical Officer: R. M.Owner: A. T.Senior Vice President Sales And Marketing: D. S.. Explore Talaris Therapeutics's employee directory with LeadIQ.

What industry does Talaris Therapeutics belong to?

Minus sign iconPlus sign iconTalaris Therapeutics operates in the Biotechnology Research industry.

What technology does Talaris Therapeutics use?

Minus sign iconPlus sign iconTalaris Therapeutics's tech stack includes Google AnalyticsDrupalModernizrreCAPTCHAX-XSS-ProtectionVimeoOpenRestyNginx.

What is Talaris Therapeutics's email format?

Minus sign iconPlus sign iconTalaris Therapeutics's email format typically follows the pattern of . Find more Talaris Therapeutics email formats with LeadIQ.

How much funding has Talaris Therapeutics raised to date?

Minus sign iconPlus sign icon As of November 2023, Talaris Therapeutics has raised $115M in funding. The last funding round occurred on Oct 06, 2020 for $115M.
Talaris Therapeutics

Talaris Therapeutics

Biotechnology ResearchKentucky, United States51-200 Employees

Beware of Job Scams: As of October 12, 2023, Talaris does not have any active job openings, and we are not conducting any hiring processes. If you come across a job posting claiming to be from Talaris, it is unauthorized and likely a scam.

Please note: Talaris will never ask for your financial information in the context of job applications. Be cautious and refrain from providing such details to anyone falsely claiming to be a recruiter on behalf of Talaris.

✕

Access Insights for Talaris Therapeutics and Millions of Other Companies

Sign up for full access to Talaris Therapeutics information.
No credit card needed
OR
By creating an account, you agree to LeadIQ's Terms of Use and Privacy Policy.

Section iconCompany Overview

Headquarters
Louisville, Kentucky 40202 US
Website
talaristx.com
SIC Code
8733 - Noncommercial Research Organizations
Stock Symbol
TRML
NAICS Code
541714 - Research and Development in Biotechnology (except Nanobiotechnology)
Employees
51-200

Section iconMedia & News

Section iconFunding & Financials

  • $115M

    Talaris Therapeutics has raised a total of $115M of funding over 2 rounds. Their latest funding round was raised on Oct 06, 2020 in the amount of $115M.

  • $10M$50M

    Talaris Therapeutics's revenue is in the range of $10M$50M

Section iconFunding & Financials

  • $115M

    Talaris Therapeutics has raised a total of $115M of funding over 2 rounds. Their latest funding round was raised on Oct 06, 2020 in the amount of $115M.

  • $10M$50M

    Talaris Therapeutics's revenue is in the range of $10M$50M

Company Leadership

Employee Directory

Ready to create more pipeline?

Get a demo and discover why thousands of SDR and Sales teams trust LeadIQ to help them build pipeline confidently.

✕

Access Insights for Talaris Therapeutics and Millions of Other Companies

Sign up for full access to Talaris Therapeutics information.
No credit card needed
OR
By creating an account, you agree to LeadIQ's Terms of Use and Privacy Policy.

Ready to create more pipeline?

Get a demo and discover why thousands of SDR and Sales teams trust
LeadIQ to help them build pipeline confidently.

© LeadIQ, Inc. All rights reserved.